Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 9,950,649,600
  • Market Capitalization, $K 9,950,650
  • Shares Outstanding, K 71,000
  • 60-Month Beta 1.19
  • Price/Earnings ttm 20.64
  • Annual Dividend & Yield 0.31 (0.22%)
  • Most Recent Dividend 0.127 on 06/15/20
  • Management Fee 0.47%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.18 +12.49%
on 06/12/20
142.33 -1.07%
on 07/07/20
+7.71 (+5.79%)
since 06/08/20
3-Month
112.39 +25.29%
on 04/09/20
142.33 -1.07%
on 07/07/20
+27.87 (+24.68%)
since 04/08/20
52-Week
92.15 +52.81%
on 03/16/20
142.33 -1.07%
on 07/07/20
+33.07 (+30.69%)
since 07/08/19

Most Recent Stories

More News
3 Hot Sector ETFs to Tide Over the Coronavirus Crisis in Q3

Here we highlight three sectors that are sizzling with investing opportunities as the second wave of the outbreak is gathering steam.

XLK : 107.72 (+1.63%)
IBB : 140.81 (+0.54%)
XHB : 45.05 (+2.11%)
ITB : 45.77 (+3.58%)
XBI : 116.77 (+1.50%)
FBT : 174.53 (+0.90%)
PKB : 30.80 (+1.51%)
FTEC : 84.92 (+1.72%)
VGT : 287.63 (+1.74%)
IYW : 280.08 (+1.77%)
Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

JNJ : 143.27 (+0.29%)
AZN : 54.19 (+1.35%)
PFE : 33.75 (-0.82%)
MRNA : 61.58 (+0.80%)
IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
ARKG : 57.63 (+2.64%)
ETF Areas for July as Second Wave of Coronavirus Hits Hard

As the COVID-19 outbreak continues to aggravate in the United States, we discuss some ETF areas that investors can consider for investing in July.

GLD : 170.09 (+0.62%)
IBB : 140.81 (+0.54%)
IAU : 17.27 (+0.58%)
XBI : 116.77 (+1.50%)
PNQI : 192.42 (+2.80%)
DOG : 47.25 (-0.61%)
FDN : 181.94 (+2.10%)
SKYY : 77.86 (+2.57%)
DXD : 18.31 (-1.40%)
CLOU : 22.90 (+2.74%)
Try These ETF Areas in Virus-Impacted Second Half of 2020

Here we highlight a few ETF areas that have the potential to do well in the second half of this year amid the coronavirus crisis.

IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
IBUY : 77.16 (+2.23%)
BOTZ : 24.69 (+0.98%)
ROBO : 44.55 (+0.95%)
IPAY : 51.09 (+1.21%)
SKYY : 77.86 (+2.57%)
CLIX : 81.64 (+2.27%)
TPAY : 34.87 (+0.99%)
CLOU : 22.90 (+2.74%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 60.84 (+1.25%)
REGN : 640.34 (-0.08%)
AMGN : 251.59 (-0.62%)
SRPT : 170.15 (+3.82%)
IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
Moderna a Step Closer to Coronavirus Vaccine: ETFs to Gain

Moderna informs that the final-stage trial's primary aim will be to prevent the spread of coronavirus.

JNJ : 143.27 (+0.29%)
AZN : 54.19 (+1.35%)
MRNA : 61.58 (+0.80%)
IBB : 140.81 (+0.54%)
CNCR : 27.76 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
IDNA : 39.59 (+1.51%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 75.61 (-1.06%)
LLY : 169.13 (+1.43%)
IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
ARKG : 57.63 (+2.64%)
These ETF Areas Make Great Investment Choices in June

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
JETS : 16.33 (+0.18%)
IBUY : 77.16 (+2.23%)
BOTZ : 24.69 (+0.98%)
SKYY : 77.86 (+2.57%)
CLIX : 81.64 (+2.27%)
IRBO : 31.00 (+1.34%)
CLOU : 22.90 (+2.74%)
U.S. Outperforms YTD: 6 Top-Ranked ETF Winners

Wall Street has staged a comeback since late March, leaving behind the rest of the world.

IBB : 140.81 (+0.54%)
QQQ : 259.99 (+1.32%)
JKE : 245.76 (+1.15%)
IGV : 297.19 (+2.04%)
FDN : 181.94 (+2.10%)
WCLD : 42.04 (+3.60%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 143.27 (+0.29%)
AZN : 54.19 (+1.35%)
MRNA : 61.58 (+0.80%)
NVAX : 98.30 (-5.99%)
IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
ARKG : 57.63 (+2.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 142.65
1st Resistance Point 141.73
Last Price 140.81
1st Support Level 139.53
2nd Support Level 138.26

See More

52-Week High 142.33
Last Price 140.81
Fibonacci 61.8% 123.16
Fibonacci 50% 117.24
Fibonacci 38.2% 111.32
52-Week Low 92.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar